This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Buffett Disciples' Two Value-Stock Picks

1. U.S. Physical Therapy (USPH - Get Report) operates outpatient physical and occupational-therapy clinics. Ostensibly, it appears to be more growth than value. But, as Buffett notes, those that differentiate between growth and value tend to misunderstand his philosophy. U.S. Physical has boosted sales 15% a year, on average, since 2007. It expanded net income 25% a year, on average, over that span as its stock delivered annualized gains of 8.4%.

Columbia's Ryan Coyle argues that U.S. Physical is a compelling value investment given secular demand growth, free cash flow and the opportunity to acquire in a fragmented marketplace. Citing the Bureau of Labor Statistics, Coyle notes that U.S. demand for physical therapy will grow 4% a year through 2016 as Baby Boomers undergo operations and injury. A demand shift and a shortage of therapists suggest that the therapy market is rife with opportunity for U.S. Physical, which held $7.2 million of cash and $4.3 million of debt in the second quarter.

The company will report third-quarter results Nov. 4. Second-quarter profit grew 23% to $4.5 million, or 38 cents a share, as revenue ascended 4.5%. U.S. Physical beat the earnings consensus by 4.7%, but its stock declined 0.6% on the news. The operating margin rose from 16% to 18%. Return on equity widened from 13% to 14% and return on assets climbed from 9.6% to 10%. U.S. Physical is loved by the sell-side. All six analysts covering the stock rate it "buy." A median target of $21.50 suggests a looming 12-month return of 13%.

Based on peer valuation, U.S. Physical is inexpensive, but not downright cheap. It trades at a trailing earnings multiple of 17, a forward earnings multiple of 14, a book value multiple of 2.3, a sales multiple of 1.1 and a cash flow multiple of 7.7, on par or at slight discounts to health-care-provider industry averages.

Institutional investors tell a different story than brokerages. In the latest quarter, 10 of the stock's 30 largest holders purchased more shares, 17 reduced their positions and two held steady. TheStreet's stock model, which is notably conservative, rates U.S. Physical "buy" with an overall grade of A-minus and a price target of $24.33.

-- Written by Jake Lynch in Boston.


Become a fan of TheStreet on Facebook.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CLGX $35.48 0.00%
USPH $49.86 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs